Inovalon Holdings Inc (NASDAQ:INOV) has received a consensus recommendation of “Hold” from the nine research firms that are covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation and five have issued a hold recommendation on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $12.00.

A number of brokerages have recently issued reports on INOV. Zacks Investment Research downgraded shares of Inovalon from a “hold” rating to a “sell” rating in a research report on Tuesday, November 7th. BidaskClub downgraded shares of Inovalon from a “sell” rating to a “strong sell” rating in a research report on Thursday, December 14th.

Shares of Inovalon (NASDAQ:INOV) traded down $0.15 during mid-day trading on Friday, hitting $12.35. 257,700 shares of the stock were exchanged, compared to its average volume of 513,392. Inovalon has a 12-month low of $10.45 and a 12-month high of $17.80. The company has a debt-to-equity ratio of 0.31, a quick ratio of 5.62 and a current ratio of 5.62. The company has a market cap of $1,823.40, a P/E ratio of 102.93, a price-to-earnings-growth ratio of 3.08 and a beta of 0.94.

In related news, insider Shauna L. Vernal sold 5,908 shares of the company’s stock in a transaction on Friday, November 17th. The shares were sold at an average price of $16.01, for a total value of $94,587.08. Following the completion of the transaction, the insider now owns 47,309 shares of the company’s stock, valued at approximately $757,417.09. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Shauna L. Vernal sold 44,270 shares of the company’s stock in a transaction on Tuesday, January 23rd. The stock was sold at an average price of $14.00, for a total transaction of $619,780.00. The disclosure for this sale can be found here. Insiders sold a total of 136,006 shares of company stock valued at $2,048,134 in the last ninety days. 48.28% of the stock is currently owned by insiders.

A number of institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in Inovalon by 3.1% in the 2nd quarter. Vanguard Group Inc. now owns 4,960,754 shares of the technology company’s stock worth $65,234,000 after buying an additional 151,473 shares during the period. BlackRock Inc. boosted its holdings in Inovalon by 1.2% in the 4th quarter. BlackRock Inc. now owns 4,168,708 shares of the technology company’s stock worth $62,531,000 after buying an additional 51,184 shares during the period. Neuberger Berman Group LLC boosted its holdings in Inovalon by 3.1% in the 3rd quarter. Neuberger Berman Group LLC now owns 1,955,690 shares of the technology company’s stock worth $33,345,000 after buying an additional 58,447 shares during the period. State Street Corp lifted its stake in Inovalon by 59.1% in the 2nd quarter. State Street Corp now owns 1,151,392 shares of the technology company’s stock worth $15,140,000 after purchasing an additional 427,528 shares in the last quarter. Finally, Senvest Management LLC lifted its stake in Inovalon by 3.0% in the 4th quarter. Senvest Management LLC now owns 1,039,700 shares of the technology company’s stock worth $15,596,000 after purchasing an additional 30,000 shares in the last quarter. 27.96% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Inovalon Holdings Inc (INOV) Receives $12.00 Average Price Target from Brokerages” was published by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this story can be read at https://www.watchlistnews.com/inovalon-holdings-inc-inov-receives-12-00-average-price-target-from-brokerages/1863660.html.

About Inovalon

Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.

Analyst Recommendations for Inovalon (NASDAQ:INOV)

Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with MarketBeat.com's FREE daily email newsletter.